A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, discusses insights from the FLAME trial analysis and the ICS-RECODE meta-analysis.

The right treatment plan can help you control your COPD symptoms and avoid exacerbations (flareups). These include shortness ...

A total of 2,802 patients with COPD were randomised 1:1 to receive ... and could include single or dual long-acting bronchodilator therapy, inhaled corticosteroid either alone or in combination ...

Dupilumab in COPD was associated with decreased risk of mortality, emergency visits, exacerbations, and respiratory failure and infections.

Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of the small airways and destruction of lung tissue. This leads to poor airflow ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

and chest tightness caused by lung diseases such as asthma and chronic obstructive pulmonary disease (COPD); a group of diseases that affect the lungs and airways. It relaxes the smooth muscles in ...